tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
US Market
ORIC
Oric Pharmaceuticals
RESEARCH TOOLSreports

Oric Pharmaceuticals (ORIC) Stock News & Sentiment

Compare
493 Followers
Constructive Buy Thesis on ORIC Driven by Differentiated PRC2 Biology and Manageable Safety Profile for Rinzimetostat
Premium
Ratings
Constructive Buy Thesis on ORIC Driven by Differentiated PRC2 Biology and Manageable Safety Profile for Rinzimetostat
14d ago
ORIC
ORIC Pharmaceuticals: Differentiated PRC2 Inhibitor Rinzimetostat Mitigates Sector Safety Overhang and Supports Buy Rating
Premium
Ratings
ORIC Pharmaceuticals: Differentiated PRC2 Inhibitor Rinzimetostat Mitigates Sector Safety Overhang and Supports Buy Rating
15d ago
ORIC
Oric Pharmaceuticals Launches New 2026 ATM Share Program
Premium
Company Announcements
Oric Pharmaceuticals Launches New 2026 ATM Share Program
29d ago
8K
ORIC
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
Premium
Stock Analysis & Ideas
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
2M ago
OLMA
ORIC
ORIC Pharmaceuticals: Dense Near‑Term Clinical Catalysts and Encouraging Efficacy Data Underpin Reiterated Buy Rating
Premium
Ratings
ORIC Pharmaceuticals: Dense Near‑Term Clinical Catalysts and Encouraging Efficacy Data Underpin Reiterated Buy Rating
2M ago
ORIC
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
Premium
Market News
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
3M ago
OLMA
ORIC
Oric Pharmaceuticals Highlights Promising Enozertinib Trial Results
Premium
Company Announcements
Oric Pharmaceuticals Highlights Promising Enozertinib Trial Results
4M ago
8K
ORIC
More ORIC News >

ORIC News on the Web

Rinzimetostat Shows Promise Against Prostate Cancer Resistance—ORIC's AACR 2026 Presentations Highlight Key Preclinical Findings
Market Chameleon
Neutral
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), MindWalk Holdings (HYFT) and Erasca (ERAS)
TipRanks News
Bullish
Oric selloff brings favorable entry point, says H.C. Wainwright
TipRanks News
Bullish
Oric Pharmaceuticals reports Q4 revenue C$17.39M vs. C$18.04M last year
TipRanks News
Neutral
Constructive Buy Thesis on ORIC Driven by Differentiated PRC2 Biology and Manageable Safety Profile for Rinzimetostat
TipRanks News
Bullish
Oric Pharmaceuticals selloff a buying opportunity, says JPMorgan
TipRanks News
Bullish
Cantor says Oric move down on tazemetostat withdrawal an ‘over-reaction’
TipRanks News
Bullish
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
ORIC
Sector Average
Media Buzz
This Week1 articles
Weekly Average6.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ORIC’s Media Buzz Sentiment?
1 articles about ORIC were published this week. In an average week, 6.25 articles are published.
    What is ORIC’s weekly average amount of articles?
    In an average week, 6.25 articles about ORIC are published.
      What is ORIC’s News Sentiment?
      50% of articles about ORIC were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        HYPRHyperfine
        KMTSKestra Medical Technologies Ltd.
        OVIDOvid Therapeutics
        PYPDPolyPid
        Showing the stocks with the most bullish news sentiment over the past week